The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Tabeeva G.R.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Sergeev A.V.

Chair of biophysical methods in medicine, Faculty of continuing medical education of the Russian University of Peoples’ Friendship;
G.N. Speransky Children's Clinical Hospital №9

Gromova S.A.

New aspects of neurobiology of migraine: the role of hypothalamic-pineal system

Authors:

Tabeeva G.R., Sergeev A.V., Gromova S.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(8): 79‑85

Read: 6027 times

Download PDF (RU)
Contact the author
Table of contents

NEW ASPECTS OF NEUROBIOLOGY OF MIGRAINE: THE ROLE OF HYPOTHALAMIC-PINEAL SYSTEM
NEW ASPECTS OF NEUROBIOLOGY OF MIGRAINE: THE ROLE OF HYPOTHALAMIC-PINEAL SYSTEM

To cite this article:

Tabeeva GR, Sergeev AV, Gromova SA. New aspects of neurobiology of migraine: the role of hypothalamic-pineal system. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(8):79‑85. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
The role of gene­tic poly­morphisms in folate meta­bolism genes in the mani­festation of migraine in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):47-52
Biochemical features of migraine pathogenesis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):21-26
Morning headaches in patients with obstructive sleep apnea syndrome: Pathogenesis, differential diagnosis, and treatment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):92-97
Modern methods of correction of age-related changes in the female body. Plastic Surgery and Aesthetic Medi­cine. 2025;(1):90-96
Angiotensin model as a new approach to study of mese­nchymal stem cell sene­scence. Russian Cardiology Bulletin. 2025;(2):20-26
Comparative analysis of preventive action of drinking sulfate mine­ral water on neurohormonal and immune regu­lation organs in radiation expo­sure to rats. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(2):45-51
Recu­rrent pain syndromes in adolescents of different ages. Russian Journal of Pain. 2025;(2):24-31
Prophylactic treatment of migraine in real clinical practice. Russian Journal of Pain. 2025;(2):63-69
Biofeedback in complex therapy of pain syndromes. Russian Journal of Pain. 2025;(2):70-75
Asso­ciations between sali­vary mela­tonin and periodontal disease: a systematic review and meta-analysis. Stomatology. 2025;(3):87-96
Abstract:

Keywords:

neurobiology
migraine
hypothalamus
pineal gland
melatonin

Authors:

Tabeeva G.R.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Sergeev A.V.

Chair of biophysical methods in medicine, Faculty of continuing medical education of the Russian University of Peoples’ Friendship;
G.N. Speransky Children's Clinical Hospital №9

Gromova S.A.

Close metadata

References:

  1. Vein A.M. Lektsii po nevrologii nespetsificheskikh sistem mozga. M 1974; 118.
  2. Dizregulyatsionnaya patologiya. Pod red. akad. RAMN G.N. Kryzhanovskogo. M: Meditsina 2002; 632.
  3. Komarov F.I., Rapoport S.I., Malinovskaya N.K., Anisimov V.N. Melatonin v norme i patologii. M 2004.
  4. Levin Ya.I. Son i bol'. Meditsina dlya vsekh 1998; 4: 27-28.
  5. Levin Ya.I., Tabeeva G.R., Khanunov I.G. Vliyanie melatonina na strukturu sna i klinicheskie proyavleniya u bol'nykh fibromialgiei. V sb: Aktual'nye voprosy somnologii. M 1998; 100.
  6. Osipova V.V., Levin Ya.I. Migren' v tsikle «son-bodrstvovanie». Zhurn nevrol i psikhiat 2006; 106: 5: 9-15.
  7. Sergeev A.V., Tabeeva G.R., Azimova Yu.E. Tsentral'naya neironal'naya gipervozbudimost' - predispozitsiya k migreni. Ros zhurn boli 2010; 27: 2: 3-12.
  8. Tabeeva G.R. Khronobiologiya migreni. Zhurn nevrol i psikhiat 2010; 110: 4: 1: 104-112.
  9. Tabeeva G.R., Yakhno N.N. Migren'. M: GOETAR-Media 2011; 327-408.
  10. Alstadhaug K.B., Salvesen R., Bekkelund S. 24-hour distribution of migraine. Headache 2008; 48: 95-100.
  11. Alstadhaug K.B., Salvesen R. Migraine-mechanisms and consequences for treatment. Tidsskr Nor Laegeforen 2007; 127: 3064-3068.
  12. Alstadhaug K.B. Periodicity of migraine. In: Clarke LB, ed. Migraine disorders research trends. New York: Nova Science 2007; 107-144.
  13. Amionff M.J., Boller F., Swaab D.F. eds. Handbook of clinical neurology, Vol. 79. The human hypothalamus: basic and clinical aspects. Part I. Amsterdam, London: Elsevier 2003.
  14. Amionff M.J., Boller F., Swaab D.F. Pain and addiction. In: Amionff M.J., Boller F., Swaab D.F. eds. Handbook of clinical neurology, Vol. 80. The human hypothalamus: basic and clinical aspects. Part II. Amsterdam, London: Elsevier 2004.
  15. Avnon Y., Nitzan M., Sprecher E. et al. Different patterns of parasympathetic activation in uni- and bilateral migraineurs. Brain 2003; 126: 1660-1670.
  16. Bahra A., Matharu S., Buchel C. et al. Brainstem activation specific to migraine headache. Lancet 2001; 357: 1016-1017.
  17. Bartsch T., Levy M.J., Knight P.J., Goadsby P.J. Inhibition of nociceptive dural input in the trigeminal nucleus caudalis by somatostatin receptor blockade in the posterior hypothalamus. Pain 2005; 117: 30-39.
  18. Benjamin L., Levy M.J., Lasalandra M.P. et al. Hypothalamic activation after stimulation of the superior sagittal sinus in the cat: a Fos study. Neurobiol Dis 2004; 16: 500-505.
  19. Bettahi I., Pozo D., Osuna C. et al. Melatonin reduces nitric oxide synthase activity in rat hypothalamus. J Pineal Res 1996; 20: 205-210.
  20. Bigal M.E., Lipton R.B., Holland P.R., Goadsby P.J. Obesity, migraine, and chronic migraine-possible mechanisms of interaction. Neurology 2007; 68: 1851-1861.
  21. Bolay H., Reuter U., Dunn A.K. et al. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 2002; 8: 136-142.
  22. Brun J., Claustrat B., Saddier P., Chazot G. Nocturnal melatonin excretion is decreased in patients with migraine without aura attacks associated with menses. Cephalalgia 1995; 15: 136-139.
  23. Burstein R., Jakubowski M. A unitary hypothesis for multiple triggers of the pain and strain of migraine. J Comp Neurol 2005; 493: 9-14.
  24. Carstens E. Hypothalamic inhibition of rat dorsal horn neuronal responses to noxious skin heating. Pain 1986; 25: 95-107.
  25. Casez O., Dananchet Y., Besson G. Migraine and somnambulism. Neurology 2005; 65: 1334-1336.
  26. Chuang J.I., Mohan N., Meltz M.L., Reiter R.J. Effect of melatonin on NF-kappa-B DNA-binding activity in the rat spleen. Cell Biol Int 1996; 20: 687-692.
  27. Claustrat B., Brun J., Geoffriau M. et al. Nocturnal plasma melatonin profile and melatonin kinetics during infusion in status migrainosus. Cephalalgia 1997; 17: 511-517.
  28. Claustrat B., Loisy C., Brun J. et al. Nocturnal plasma melatonin levels in migraine: a preliminary report. Headache 1989; 29: 242-245.
  29. Dahmen N., Kasten M., Wieczorek S. et al. Increased frequency of migraine in narcoleptic patients: a confirmatory study. Cephalalgia 2003; 23: 14-19.
  30. De Vries M.W., Peeters F.P. Melatonin as a therapeutic agent in the treatment of sleep disturbance in depression. J Nerv Ment Dis 1997; 185: 201-202.
  31. Della Marca G., Vollono C., Rubino M. et al. Dysfunction of arousal systems in sleep-related migraine without aura. Cephalalgia 2006; 26: 857-864.
  32. Denuelle M., Fabre N., Payoux P. et al. Hypothalamic activation in spontaneous migraine attacks. Headache 2007; 47: 1418-1426.
  33. Dexter J.D. The relationship between stage III + IV + REM sleep and arousals with migraine. Headache 1979; 19: 364-369.
  34. Dubbels R., Reiter R.J., Klenke E. et al. Melatonin in edible plants identified by radioimmunoassay and by high performance liquid chromatography-mass spectrometry. J Pineal Res 1995; 18: 28-31.
  35. Ebadi M., Govitrapong P., Phansuwan-Pujito P. et al. Pineal opioid receptors and analgesic action of melatonin. J Pineal Res 1998; 24: 193-200.
  36. Epstein M.T., Hockaday J.M., Hockaday T.D. Migraine and reproductive hormones throughout the menstrual cycle. Lancet 1975; 1: 543-548.
  37. Espinar A., Garcia-Oliva A., Isorna E.M. et al. Neuroprotection by melatonin from glutamate-induced excitotoxicity during development of the cerebellum in the chick embryo. J Pineal Res 2000; 28: 81-88.
  38. Facchinetti F., Sgarbi L., Piccinini F. Hypothalamic resetting at puberty and the sexual dimorphism of migraine. Funct Neurol 2000; 15: Suppl 3: 137-142.
  39. Galego J.C., Cipullo J.P., Cordeiro J.A., Tognola W.A. Clinical features of episodic migraine and transformed migraine: a comparative study. Arq Neuropsiquiatr 2002; 60: 912-916.
  40. Garcia J.J., Reiter R.J., Guerrero J.M. et al. Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett 1997; 408: 297-300.
  41. Giffin N.J., Ruggiero L., Lipton R.B. et al. Premonitory symptoms in migraine. An electronic diary study. Neurology 2003; 60: 935-940.
  42. Goder R., Fritzer G., Kapsokalyvas A. et al. Polysomnographic findings in nights preceding a migraine attack. Cephalalgia 2001; 21: 31-37.
  43. Godson C., Reppert S.M. The Mel1a melatonin receptor is coupled to parallel signal transduction pathways. Endocrinology 1997; 138: 397-404.
  44. Gori S., Morelli N., Maestri M. et al. Sleep quality, chronotypes and preferential timing of attacks in migraine without aura. J Headache Pain 2005; 6: 258-260.
  45. Granella F., Sances G., Zanferrari C. et al. Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache 1993; 33: 385-389.
  46. Guldiken B., Guldiken S., Demir M. et al. Low leptin levels in migraine: a case control study. Headache 2008; 48: 1103-1107.
  47. Haut S.R., Bigal M.E., Lipton R.B. Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol 2006; 5: 148-157.
  48. Hunt S.P., Pini A., Evan G. Introduction of c-fos like protein in spinal cord neurons following sensory stimulation. Nature 1987; 328: 1686-1704.
  49. Kalsbeek A., Palm I.F., La Fleur S.E. et al. SCN outputs and the hypothalamic balance of life. J Biol Rhythms 2006; 21: 458-469.
  50. Kutlu S., Ozcan M., Canpolat S. et al. Effect of Ghrelin on pain threshold in mice. Firat Tip Dergisi 2005; 10: 89-91.
  51. Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain 1994; 117: 199-210.
  52. Lichten E.M., Lichten J.B., Whitty A., Pieper D. The confirmation of a biochemical marker for women's hormonal migraine: the depo-estradiol challenge test. Headache 1996; 35: 367-371.
  53. Lu J., Sherman D., Devor M., Saper C.B. A putative flip-flop switch for control of REM sleep. Nature 2006; 441: 589-594.
  54. Lund I., Ge Y., Yu L.C. et al. Repeated massage-like stimulation induces long-term effects on nociception-contribution of oxytocinergic mechanisms. Eur J Neurosci 2002; 16: 330-338.
  55. Malick A., Jakubowski M., Elmquist J.K. et al. A neurohistochemical blueprint for pain-induced loss of appetite. Proc Natl Acad Sci USA 2001; 98: 9930-9935.
  56. Malick A., Strassman A.M., Burnstein R. Trigeminohypothalamic and reticulohypothalamic tract neurons in the upper cervical spinal cord and caudal medulla of the rat. J Neurophysiol 2000; 84: 2078-2112.
  57. Markey S.P., Higa S., Shih M. et al. The correlation between human plasma melatonin levels and urinary 6-hydroxymelatonin excretion. Clin Chim Acta 1985; 150: 221-225.
  58. Medina J.L., Diamond S. Cyclical migraine. Arch Neurol 1981; 38: 343-344.
  59. Menendez-Pelaez A., Poeggeler B., Reiter R.J. et al. Nuclear localization of melatonin in different mammalian tissues: immunocytochemical and radioimmunoassay evidence. J Cell Biochem 1993; 53: 373-382.
  60. Monnet F.P. Melatonin modulates [3h] serotonin release in the rat hippocampus: effects of circadian rhythm. J Neuroendocrinol 2002; 14: 194-199.
  61. Murialdo G., Fonzi S., Costelli P. et al. Urinary melatonin excretion throughout the ovarian cycle in menstrually related migraine. Cephalalgia 1994; 14: 205-209.
  62. Nagtegaal J.E., Laurant M.W., Kerkhof G.A. et al. Effects of melatonin on the quality of life in patients with delayed sleep phase syndrome. J Psychosom Res 2000; 48: 45-50.
  63. Orts R.J., Benson B. Inhibition effects on serum and pituitary LH by a melatonin-free extract of bovine pineal glands. Life Sci II 1973; 12: 513-519.
  64. Overem S., van Vliet J.A., Lammers G.J. et al. The hypothalamus in episodic brain disorders. Lancet Neurol 2002; 1: 437-444.
  65. Paiva T., Batista A., Martins P., Martins A. The relationship between headaches and sleep disturbances. Headache 1995; 35: 590-596.
  66. Peres M.F., Sanchez del Rio M., Seabra M.L. et al. Hypothalamic involvement in chronic migraine. J Neurol Neurosurg Psychiatry 2001; 71: 747-751.
  67. Peres M.F., Stiles M.A., Siow H.C. et al. Chronobiological features in episodic and chronic migraine. Cephalalgia 2003; 23: 590-591.
  68. Peres M.F., Zukerman E., da Cunha Tanuri F. et al. Melatonin 3 mg, is effective for migraine prevention. Neurology 2004; 63: 757.
  69. Peres M.F.P. Melatonin, the pineal gland and their implications for headache disorders. Cephalalgia 2005; 25: 403-411.
  70. Perotuka S.J. Migraine: a chronic sympathetic nervous system disorder. Headache 2004; 44: 53-64.
  71. Peroutka S.J. Dopamine and migraine. Neurology 1997; 49: 650-656.
  72. Poole C.J.M., Lightman S.L. Inhibition of vasopressin secretion during migraine. J Neurol Neurosurg Psychiatry 1988; 51: 1441-1444.
  73. Ramadan N.M. The link between glutamate and migraine. CNS Spectr 2003; 8: 446-449.
  74. Reiter R.J., Calvo J.R., Karbownik M. et al. Melatonin and its relation to the immune system and inflammation. Ann NY Acad Sci 2000; 917: 376-386.
  75. Reiter R.J. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991; 12: 151-180.
  76. Reppert S.M., Godson C., Mahle C.D. et al. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci USA 1995; 92: 8734-8738.
  77. Sances G., Granella F., Nappi R.E. et al. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 2003; 23: 197-205.
  78. Savaskan E., Olivieri G., Brydon L. et al. Cerebrovascular melatonin MT1-receptor alterations in patients with Alzheimer's disease. Neurosci Lett 2001; 308: 9-12.
  79. Shaikh A.Y., Xu J., Wu Y. et al. Melatonin protects bovine cerebral endothelial cells from hyperoxia-induced DNA damage and death. Neurosci Lett 1997; 229: 193-197.
  80. Silberstein S.D., Elkind A.H., Schreiber C., Keywood C. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology 2004; 63: 261-269.
  81. Silberstein S.D. The role of sex hormones in headache. Neurology 1992; 42: 3 Suppl 2: 37-42.
  82. Stewart W.F., Shechter A., Rasmussen B.K. Migraine prevalence: a review of population-based studies. Neurology 1994; 44: Suppl 4: 17-23.
  83. Wang F., Li J.C., Wu C.F. et al. Hypnotic activity of melatonin: involvement of semicarbazide hydrochloride, blocker of synthetic enzyme for GABA. Acta Pharmacol Sin 2002; 23: 860-864.
  84. Weiler C., May A., Limmroth V. et al. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995; 1: 658-660.
  85. Wu F.S., Yang Y.C., Tsai J.J. Melatonin potentiates the GABA(A) receptor-mediated current in cultured chick spinal cord neurons. Neurosci Lett 1999; 260: 177-180.
  86. Young W.B., Peres M.F., Rozen T.D. Modular headache theory. Cephalalgia 2001; 21: 842-849.
  87. Zang L.Y., Cosma G., Gardner H., Vallyathan V. Scavenging of reactive oxygen species by melatonin. Biochim Biophys Acta 1998; 1425: 469-477.
  88. Zhang Q.Z., Gong Y.S., Zhang J.T. Antagonistic effects of melatonin on glutamate release and neurotoxicity in cerebral cortex. Zhongguo Yao Li Xue Bao 1999; 20: 829-834.
  89. Zisapel N. Melatonin-dopamine interactions: from basic neurochemistry to a clinical setting. Cell Mol Neurobiol 2001; 21: 605-616.
  90. Zurak N. Role of the suprachiasmatic nucleus in the pathogenesis of migraine attacks. Cephalalgia 1997; 17: 723-728.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.